<SEC-DOCUMENT>0001104659-17-035349-index.html : 20170525
<SEC-HEADER>0001104659-17-035349.hdr.sgml : 20170525
<ACCEPTANCE-DATETIME>20170525205822
ACCESSION NUMBER:		0001104659-17-035349
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170523
FILED AS OF DATE:		20170525
DATE AS OF CHANGE:		20170525

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Talbot George Harrison
		CENTRAL INDEX KEY:			0001554194

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		17871526

	MAIL ADDRESS:	
		STREET 1:		C/O DURATA THERAPEUTICS, INC.
		STREET 2:		89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR
		CITY:			MORRISTOWN
		STATE:			NJ
		ZIP:			07960
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>a4.xml
<DESCRIPTION>4
<TEXT>
Document 1 - file: a4.html

Document 1 - RAW XML: a4.xml

</DOCUMENT>
</SEC-DOCUMENT>